Vol. 2 — March-April 2007

• Surrogate end points in clinical trials: the case of anti-neutrophil cytoplasm antibody-associated vasculitis
  

  M. Walsh¹, Marcello Tonelli², D. Jayne³, B. Manns⁴

  (1) Vasculitis and Lupus Clinic, Department of Renal Medicine, Addenbrooke's Hospital, Cambridge - UK an
  (2) Department of Medicine, Department of Critical Care, and Institute of Health Economics, University o
  (3) Vasculitis and Lupus Clinic, Department of Renal Medicine, Addenbrooke's Hospital, Cambridge - UK
  (4) Department of Community Health Sciences, University of Calgary, Calgary and Institute of Health Econ

• Novel insights into the regulation of systemic phosphate homeostasis and renal phosphate excretion
  

  Carsten A. Wagner¹

  (1) Institute of Physiology and Zurich Center for Integrative Human Physiology, University of Zurich, Zu

• Focus on hypertension
  

  Francesca Tentori¹

  (1) Arbor Research Collaborative for Health, Ann Arbor, Michigan - USA

• Clinical epidemiology of arteriovenous fistula in 2007
  

  Pietro Ravani¹, L.M. Spergel², A. Asif³, P. Roy-Chaudhury⁴, A. Besarab⁵

  (1) Clinical Epidemiology Unit, Memorial University of Newfoundland, St. John's, Newfoundland - Canada a
  (2) Dialysis Management Medical Group, San Francisco, California - USA
  (3) Division of Nephrology, Department of Medicine, Miller School of Medicine, University of Miami, Miam
  (4) Division of Nephrology and Hypertension, University of Cincinnati, Cincinnati, Ohio - USA
  (5) Division of Nephrology and Hypertension, Henry Ford Health System, Detroit, Michigan - USA

• Biology of arteriovenous fistula failure
  

  P. Roy-Chaudhury¹, L.M. Spergel², A. Besarab³, A. Asif⁴, Pietro Ravani⁵

  (1) Division of Nephrology and Hypertension, University of Cincinnati, Cincinnati, Ohio - USA
  (2) Dialysis Management Medical Group, San Francisco, California - USA
  (3) Division of Nephrology and Hypertension, Henry Ford Health System, Detroit, Michigan - USA
  (4) Division of Nephrology, Department of Medicine, Miller School of Medicine, University of Miami, Miam
  (5) Clinical Epidemiology Unit, Memorial University of Newfoundland, St. John's, Newfoundland - Canada a

• Phosphatemia is related to chromosomal aberrations of parathyroid glands in patients with hyperparathyroidism
  

  J. Chudek¹, A. Nagy², F. Kokot¹, A. Podwinski³, Andrzej Wiecek¹, Eberhard Ritz, G. Kovacs²

  (1) Department of Nephrology, Endocrinology and Metabolic Diseases, Silesian Medical University, Katowic
  (2) Laboratory of Molecular Oncology, Ruprecht-Karls University, Heidelberg - Germany
  (3) Department of Surgery, Silesian Medical University, Bytom - Poland

• Simultaneous pancreas-kidney transplant: a single-center long-term outcome
  

  M.L. Aguera¹, M.D. Navarro¹, R. Perez-Calderon¹, A. Rodriguez-Benot¹, R. Ojeda¹, C. Valle¹, J. Padillo², M.J. Requena³, M. Rodriguez¹, D. del Castillo¹, P. Aljama¹

  (1) Department of Nephrology, University Hospital Reina Sofia, Cordoba - Spain
  (2) Department of Surgery, University Hospital Reina Sofia, Cordoba - Spain
  (3) Department of Urology, University Hospital Reina Sofia, Cordoba - Spain

• TGF-beta1 in chronic allograft nephropathy following renal transplantation
  

  S. Harris¹, B.M. Coupes¹, S.A. Roberts², I.S.D. Roberts³, C.D. Short¹, P.E.C Brenchley¹

  (1) The Renal Research Laboratories, Manchester Institute of Nephrology and Transplantation, Manchester
  (2) Biostatistics Group of the School of Epidemiology and Health Sciences, University of Manchester, Man
  (3) Department of Cellular Pathology, John Radcliffe Hospital, Oxford - UK

• Nerve growth factor (NGF) and NGF-receptor expression in diseased human kidneys
  

  R. Bonofiglio¹, M.T. Antonucci², T. Papalia¹, F. Romeo³, G. Capocasale³, M.C. Caroleo⁴, V. Di Fausto², L. Aloe²

  (1) Department of Nephrology, Hospital Annunziata, Cosenza - Italy
  (2) Institute of Neurobiology and Molecular Medicine, NGF Section CNR, Rome - Italy
  (3) Department of Pathology, Hospital Annunziata, Cosenza - Italy
  (4) Department of Pharmacobiology, University of Calabria, Cosenza - Italy

• The effect of serum albumin level on iron-induced oxidative stress in chronic renal failure patients
  

  M.T. Sezer¹, H. Akin², M. Demir¹, J. Erturk³, Z.D. Aydin², E. Savik⁴, N. Tunc⁵

  (1) Division of Nephrology, Department of Internal Medicine, School of Medicine, Suleyman Demirel Univer
  (2) Department of Internal Medicine, School of Medicine, Suleyman Demirel University, Isparta - Turkey
  (3) Dialysis Unit, School of Medicine, Suleyman Demirel University, Isparta - Turkey
  (4) Department of Biochemistry, School of Medicine, Suleyman Demirel University, Isparta - Turkey
  (5) RTS Gulbahcesi Dialysis Center, Isparta - Turkey

• Urinary albumin excretion associated with arterial wall stiffness rather than thickness in type 2 diabetic patients
  

  E. Ishimura¹, H. Taniwaki², T. Tsuchida¹, N. Obatake², M. Emoto², T. Shoji², A. Shioi³, M. Inaba², Y. Nishizawa²

  (1) Department of Nephrology, Osaka City University Graduate School of Medicine, Osaka - Japan
  (2) Department of Endocrinology, Metabolism and Molecular Medicine, Osaka City University Graduate Schoo
  (3) Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka - Ja

• Comparison of lipid measures and risk stratification among end-stage renal disease patients
  

  R.G. Bowden¹, S. Hebert¹, R. Wilson², M. Gentile³, B.A. Lanning¹

  (1) Department of Health, Human Performance, and Recreation, Baylor University, Waco, Texas - USA
  (2) Central Texas Nephrology Associates, Waco, Texas - USA
  (3) Brazos Kidney Center, Waco, Texas - USA

• Cystatin C in heart failure is nothing more than a bystander of glomerular filtration
  

  M. Codognotto¹, A. Piccoli¹, M. Zaninotto², M. Mion², U. Vertolli¹, F. Tona³, G.M. Boffa³

  (1) Division of Nephrology, University Hospital, University of Padova, Padova - Italy
  (2) Division of Laboratory Medicine, University Hospital, University of Padova, Padova - Italy
  (3) Division of Cardiology, University Hospital, University of Padova, Padova - Italy

• A role for enhanced integrin and FAK expression in uremia-induced parathyroid hyperplasia
  

  M.V. Arcidiacono¹, M. Cozzolino², D. Brancaccio², M. Gallieni², E. Lesma¹, S. Carelli¹, A. Gorio¹, A.M. Di Giulio¹

  (1) Pharmacological Laboratories, Department of Medicine, Surgery, and Dentistry, San Paolo Hospital, Un
  (2) Renal Division, Department of Medicine, Surgery, and Dentistry, San Paolo Hospital, University of Mi

• Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis
  

  E. Bahat¹, B. Kilicarslan Akkaya², S. Akman³, G. Karpuzoglu², A. Gur Guven³

  (1) Department of Pediatric Nephrology, Faculty of Medicine, Karadeniz Technical University, Trabzon - T
  (2) Department of Pathology, Faculty of Medicine, Akdeniz University, Antalya - Turkey
  (3) Department of Pediatric Nephrology, Faculty of Medicine, Akdeniz University, Antalya - Turkey

• Recurrent hemolytic uremic syndrome associated with intestinal lymphangiectasia
  

  S. Kalman¹, S. Bakkaloglu¹, B. Dalgic², O. Ozkaya¹, O. Soylemezoglu¹, N. Buyan¹

  (1) Department of Pediatric Nephrology, Gazi University, Besevler, Ankara - Turkey
  (2) Department of Pediatric Gastroenterology, Gazi University, Besevler, Ankara - Turkey